Food and Drug Administration's Obesity Drug Guidance Document A Short History

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2012-05, Vol.125 (17), p.2156-2164
1. Verfasser:	COLMAN, Eric
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Advisory Committees - history Aged Anti-Obesity Agents - adverse effects Anti-Obesity Agents - history Anti-Obesity Agents - therapeutic use Bariatric Medicine - history Biological and medical sciences Blood and lymphatic vessels Body Mass Index Cardiology. Vascular system Child Congresses as Topic - history Cyclobutanes - therapeutic use Diabetes Mellitus, Type 2 - epidemiology Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Drug Approval Drug Discovery Drug toxicity and drugs side effects treatment Female History, 20th Century History, 21st Century Humans Male Medical sciences Middle Aged Miscellaneous (drug allergy, mutagens, teratogens...) Multicenter Studies as Topic Obesity - drug therapy Obesity - epidemiology Obesity - history Outcome Assessment (Health Care) Pharmacology. Drug treatments Piperidines - adverse effects Piperidines - therapeutic use Practice Guidelines as Topic Pyrazoles - adverse effects Pyrazoles - therapeutic use Randomized Controlled Trials as Topic Reference Standards Safety-Based Drug Withdrawals United States - epidemiology United States Food and Drug Administration - history
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!